Table of Contents Table of Contents
Previous Page  452 / 1082 Next Page
Information
Show Menu
Previous Page 452 / 1082 Next Page
Page Background

S437

ESTRO 36 2017

_______________________________________________________________________________________________

quality. Furthermore this approach enables the

identification of problematic plans beforehand.

PO-0822 An evolutionary model improvement strategy

for knowledge-based planning

Y. Zhang

1

, F. Jiang

1

, H. Yue

1

, S. Li

1

, Q. Hu

1

, M. Wang

2

, H.

Wu

1

1

Key Laboratory of Carcinogenesis and Translational

Research Ministry of Education/Beijing- Department of

Radiation Oncology- Peking University Cancer Hospital &

Institute, Department of Radiation Oncology, Beijing,

China

2

National Institute for Radiological Protection- China

CDC, National Institute for Radiological Protection-,

Beijing, China

Purpose or Objective

It was reported that RapidPlan, a knowledge-based

solution, can improve planning efficiency, quality and

consistency. Should the performance of RapidPlan be

dependent on the quality of the plans training the model,

this study hypothesizes that RapidPlan can improve its

constituent plans (closed-loop) and improve the model

itself by incorporating the better knowledge (evolution).

Moreover, the maximum number of iterations to exhaust

the full potential was also tested.

Material and Methods

An initial RapidPlan model (M

0

) for pre-surgical rectal

cancer patients was configured using 81 best-effort

manual VMAT plans (P

0

) with SIB (50.6 Gy and 41.8 Gy to

95% PTV

boost

and PTV respectively). For simplification,

decreased or increased mean dose to both femoral head

(FH) and urinary bladder (UB) were considered as

improved (P

+

) or worsened plans (P

-

) respectively. P

±

denoted intertwined plans. The first closed-loop iteration

of re-optimizing P

0

using M

0

yielded P

1

: 69 P

1+

, 12 P

and

0 P

1-

. By substituting P

1+

for their corresponding P

0

, the

library of model M

1+

consisted of 12 P

0

and 69 P

1+

. The

second closed-loop iteration of re-optimizing P

0

using M

1+

produced 35 P

2+

that were superior to both P

0

and P

1

,

hence the knowledge base of M

2+

composed 9 P

0

, 37 P

1+

and 35 P

2+

. As open-loop validation, 30 clinical plans (P

v

)

that were not included in the model were re-optimized

using each model. Re-optimization maintained all

parameters except the MLC sequences were redesigned

using the objectives generated by the models.

Renormalizations to target prescriptions were performed

to make OAR dose comparable.

Results

Consistent with literature, knowledge-based so lution

improved the plan quality in both closed- and open-loop

validations than the conventional trial-and-error process.

In the first closed-loop evolution, the mean±SD of D

mean_FH

and D

mean_UB

for 69 P

1+

were 12.88±1.38 Gy and 23.06±3.11

Gy respectively, which were significantly lower by 23.70%

and 9.53% than the corresponding values of P

0

(P<0.05). In

the second round of closed-loop re-optimization, the

D

mean_FH

of the 35 P

2+

decreased to 11.12±1.48 Gy

(corresponding P

0

: 17.13±2.06 Gy; P

1

: 13.08±1.36 Gy), and

D

mean_UB

decreased to 22.80±3.72 Gy (corresponding P

0

:

25.79±3.34 Gy; P

1

: 23.41±3.59 Gy). Table 1 and figure 1

display the open-loop validation results for various

models. The marginal disparities of HI and CI

(magnitudes

0.04) and largely overlapped DVH lines

indicated comparable target dose distribution. In line with

the closed-loop test, RapidPlan reduced the dose to OARs

massively than clinical plans in the open-loop validation

(Fig 1). The first model evolution has greatly and

significantly lowered the dose to FH at comparable dose

to the UB and targets. The second iteration has made little

difference though.

Conclusion

RapidPlan model evolves when the sub-optimal

constituent training sets were replaced by the improved

plans that were re-optimized by the model. One iteration

is most cost-effective.

PO-0823 Hierarchical constrained optimization for

automated SBRT paraspinal IMRT planning

M. Zarepisheh

1

, L. Hong

1

, J.G. Mechalakos

1

, M.A. Hunt

1

,

G.S. Mageras

1

, J.O. Deasy

1

1

Memorial Sloan Kettering, Medical Physics, New York,

United States Minor Outlying Island

Purpose or Objective

To develop a fully automated approach to IMRT treatment

planning using hierarchical constrained optimization and

the Eclipse API for SBRT paraspinal cases.

Material and Methods

This study formulates the IMRT treatment planning

problem as a hierarchical constrained optimization (HCO)

problem (also known as prioritized optimization). HCO

prioritizes the clinical goals and optimizes them in ordered

steps. In this study, we maximize tumor coverage first and

then minimize critical organ doses in the subsequent steps

based on their clinical priorities (e.g., (1) maximize tumor

coverage, (2) minimize cord or cauda dose, (3) minimize

esophagus dose,...). For each organ we define an

objective function, based on the gEUD concept, which

correlates with the clinical criterion. At each step, we

preserve the results obtained in the prior steps by treating

them as hard constraints with a slight relaxation or ”slip”

to provide space for subsequent improvement. Maximum

dose criteria to the tumor and other organs is always

respected through hard constraints applied at all steps.

To solve the resultant large-scale constrained

optimization problems, we use two commerical solvers,

knitro

and

ampl

. The Eclipse API is used to pull patient

data needed for optimization (e.g., beam geometries,